Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
BCP Investment M&A Deal with Investcorp Credit Management BDC, Inc.
BCP Investment Corp (BCIC) has entered into a definitive agreement to acquire Investcorp Credit Management BDC, Inc. (ICMB) in a merger transaction. ICMB stockholders will receive consideration equal to 90% of ICMB's net asset value at closing, paid primarily in BCIC shares with a cash component if the share issuance exceeds a 19.99% cap. The deal is intended to drive sector consolidation and generate cost synergies through increased scale.
Counterparty
Investcorp Credit Management BDC, Inc.
“This transaction marks another step in executing our vision of driving consolidation across the BDC sector. We have long believed that greater scale can deliver meaningful benefits, and the combination of ICMB and BCIC is expected to generate immediate cost synergies, lower financing costs and improved trading liquidity. We believe these benefits will position the combined company to deliver stronger long-term value for stockholders.”
Ted Goldthorpe, Chief Executive Officer and Chairman of the Board of BCIC
“This transaction reflects ICMB’s longstanding commitment to pursuing optimal returns for our stockholders. We believe the combination with BCIC positions the Company to deliver long-term value for stockholders. ICMB’s size and scale have been challenging to navigate in current market conditions. We believe that a combination with BCIC provides our stockholders the benefits of scale and access that Sierra Crest brings in the private credit market.”
Suhail A. Shaikh, President and Chief Executive Officer of ICMB
Moleculin Biotech announced the grant of Australian Patent No. 2020303572, which covers the preparation of preliposomal Annamycin lyophilizate. The patent was granted jointly to Moleculin and The Board of Regents of The University of Texas System, strengthening the company's international intellectual property portfolio for its lead drug candidate, Annamycin.
Counterparty
The Board of Regents of The University of Texas System
OneWater Marine $547M Debt Financing with Truist Bank
OneWater Marine Inc. entered into amendments for its senior secured term loan and floor plan credit facilities, extending their maturities to July 2029 and March 2029, respectively. The amendment to the inventory financing agreement also increased the maximum borrowing capacity by $50.0 million to a total of $547.1 million.
Value
$547M
Counterparty
Truist Bank and Wells Fargo Commercial Distribution Finance, LLC
Presurance Holdings, Inc. reported net income of $3.5 million for the nine months ended September 30, 2026, a significant improvement from a $1.4 million loss in the prior year period, driven largely by a $5.7 million gain from the change in fair value of contingent considerations. Total shareholders' equity increased to $24.2 million following a $14.0 million common stock issuance, despite a decrease in total assets to $202.2 million.
Corteva reported third-quarter 2026 financial results, with net sales of $1.59 billion, a 9% decrease compared to the prior year. The company updated its full-year 2026 guidance, lowering expectations due to weaker market conditions in Brazil and pricing pressure on older molecules.
“We executed well against the things we can control. New products performed strongly, productivity delivered, and we generated broad-based organic growth outside Latin America. The pressure remains concentrated. Acetochlor pricing in the U.S. was consistent with our expectations, but Brazil was materially weaker than anticipated. While those conditions are reflected in our updated outlook, our strategy has not changed. Innovation, productivity and disciplined execution remain the foundation for sustainable long-term growth.”
Donegal Group Sr. VP Kristi Spencer Altshuler Sells $114K of Stock
Kristi Spencer Altshuler, Sr. VP, sold 6,000 shares of Donegal Group Inc at $19.01 a share, worth $114K in total on Nov 10, 2026. Shares held after the trade: 0 (-100.0%).
Ellington Financial Inc. completed the sale of its mortgage servicing rights (MSR) related investments and excess servicing spread investments to an unaffiliated third party. The assets were originally acquired through the 2023 acquisition of Arlington Asset Investment Corp. and the sale is expected to free up more than $75 million in cash for redeployment into core strategies.
Neuronetics, Inc. entered into an underwriting agreement to sell 18,750,000 shares of common stock at $1.60 per share, with an additional 2,812,500 shares available via an underwriters' option. The company expects to raise approximately $30 million in gross proceeds ($27.7 million net) to repay debt under its Perceptive Credit Facility and for general corporate purposes.
Boost Run Inc. reported a significant revenue increase to $81.97 million for the nine months ended September 30, 2026, compared to $19.30 million in the prior year. However, the company experienced a substantial net loss of $93.27 million during this period, driven by increased depreciation, amortization, and a large deferred tax liability provision.
Alliance Entertainment reported first quarter fiscal 2027 results with revenue increasing 10% to $278.8 million and GAAP net income growing 56% to $7.6 million. The growth was driven by strong performance in physical movies, vinyl, and a significant 87% increase in collectibles revenue.
Term
Q1 2027
“Fiscal 2027 is off to a strong start, with 10% revenue growth, higher gross margins and significant improvement in GAAP net income and earnings per share. Physical music, movies and collectibles all grew, with collectibles revenue up 87%. For a long time, so much of the conversation was about streaming replacing physical formats. But what we’ve seen consistently is t”
Jeff Walker, Chief Executive Officer of Alliance Entertainment
Yesway, Inc. reported a significant increase in nine-month revenue to $2.57 billion in 2026, up from $1.99 billion in 2025, driven by its IPO and recapitalization transactions. Net income for the nine-month period more than doubled to $84.7 million, while the company successfully redeemed its $251.5 million in senior preferred membership interests following the public offering.
DeFi Development Corp. has appointed its current Chief Financial Officer, Fei (John) Han, to the additional role of Chief Operating Officer, effective November 9, 2026. Mr. Han will maintain his CFO responsibilities while overseeing day-to-day business operations and organizational execution. The company confirmed there will be no changes to his current compensation as a result of this expanded leadership role.
RUM Group Inc. filed its 10-Q following a significant business combination with Northern Data AG, shifting its focus toward AI infrastructure and cloud services alongside its existing video platform. The company reported outstanding shares across three classes of common stock totaling approximately 496 million shares as of November 6, 2026, and identified as an emerging growth company and non-accelerated filer.
Alliance Entertainment Holding Corp reported net revenues of $278.8 million for the quarter ended September 30, 2026, a 9.8% increase compared to the same period in 2025. Net income rose to $7.6 million ($0.15 per share) from $4.9 million ($0.10 per share) year-over-year, driven by higher sales volume and a significant decrease in interest expense.
Nortech Systems reported Q3 2026 net sales of $33.0 million, an 8.4% increase year-over-year, and returned to profitability with net income of $637 thousand. The company's total backlog grew 20% to $92.8 million, driven by strength in Aerospace & Defense and Industrial markets.
Term
Q3 2026
“Our third quarter results reflect continued execution of our business strategy. We are deepening engineering partnerships with our customers, using our manufacturing footprint across the United States, Mexico, and China to serve them from the location that best meets their needs, and strengthening operational discipline across our global operations.”
Jay D. Miller, President & CEO
“Total backlog of $92.8 million is up 20% from a year ago, led by Aerospace & Defense and Industrial markets, and gives us confidence in the direction of the business. Our China operations, where net sales grew more than 56% in the quarter, continue to demonstrate the value of our global footprint.”
Bloomia Holdings reported financial results for its first fiscal quarter ended September 30, 2026, with revenue of $5.0 million and a net loss of $2.4 million. Management highlighted a 17% improvement in net loss and a 21% improvement in Adjusted EBITDA compared to the prior year, driven by operational process improvements and lower bulb prices.
Term
Q1 2027
“Our revenue remained stable during the quarter, while we continued to make meaningful progress on the key operational and financial initiatives that are strengthening Bloomia's foundation for long-term growth. This progress is evident in our quarter’s results, where we improved our net loss by 17% and our adjusted EBITDA by 21% over the comparable prior year quarter. Further, we used significantly less cash in the quarter as Dutch bulb prices dropped materially year-over-year. This both strengthens our balance sheet by preserving cash, and leads to improved operating margins for the year ahead.”
Mark Jundt, Chairman and Co-Chief Executive Officer
“Our first fiscal quarter is where we lay the foundation for a successful year. We have dug deep into analyzing our core operating processes, resulting in many process improvements that are simultaneously increasing quality and decreasing waste. We are set up for a year of growth in terms of both revenue and profitability.”
NextTrip announced an expansion of its cruise strategy by integrating JOURNY TV programming with JOURNYGO digital booking tools and Five Star Alliance travel advisor support. The initiative utilizes the Storybook platform to provide live pricing and itineraries from over 35 cruise lines, aiming to convert media viewers into travel customers.
Agassi Sports Entertainment Corp. entered into media value agreements with Sinclair Television Group and The Tennis Channel to receive $1.5 million in advertising inventory across television and digital platforms. In exchange, the company issued 300,000 shares of restricted common stock valued at $5.00 per share to the media providers. The partnership aims to build brand visibility for the company's racket sports initiatives, including the Agassi App and the World Series of Pickleball.
VolitionRx CEO Cameron Reynolds agreed to a further temporary reduction in his annual base salary from $355,456 to $236,970.50 as part of the company's cost-reduction measures. This follows a previous 25% reduction effective February 2026, bringing his total salary down from a contractual base of $473,941. The reduction will remain in effect until the Compensation Committee determines the company's financial stability is secured, potentially following a significant licensing or commercial agreement.
SpyGlass Pharma reported a net loss of $57.9 million for the nine months ended September 30, 2026, compared to $27.3 million in the prior year, driven by increased R&D and G&A expenses. The company significantly strengthened its balance sheet through an initial public offering and the conversion of preferred stock, ending the period with $208.7 million in cash and cash equivalents.
M2i Global Signs $100M M&A Deal with Happy Growth Group Limited
M2i Global entered into a definitive agreement to acquire 100% of Graphex Technologies LLC (GTL) from Happy Growth Group Limited for $100 million. The purchase price consists of $3 million in cash (via a note) and $97 million in common stock tranches tied to the delivery of a design and completion of a 50,000 metric ton per year graphite anode production plant in the U.S. The acquisition includes an exclusive license to 30 patents for natural graphite anode production across North America.
HeartCore Enterprises Partnership with ONE AI Co., Ltd.
HeartCore Enterprises entered into a non-exclusive business development and sales agency agreement with ONE AI Co., Ltd. to bring the Axis.ONE physical AI platform to industrial robots in Japan. The partnership aims to retrofit existing factory equipment with CPU-native, on-device AI capabilities for vision and decision-making without requiring GPU clusters or cloud dependency.
GT Biopharma shareholders approved a significant increase in authorized common shares from 25 million to 250 million and authorized the issuance of more than 19.99% of outstanding stock. These approvals facilitate the conversion of Series M Preferred Stock and the exercise of warrants related to a Securities Purchase Agreement dated September 14, 2026. The vote ensures compliance with Nasdaq Rule 5635 regarding the potential dilution from these previously announced financing transactions.
VisionWave Holdings Signs $7M M&A Deal with Europostachservice LLC
VisionWave Holdings entered into a non-binding Letter of Intent to acquire a 51% controlling interest in EPSERVICE, a Ukrainian developer of unmanned aerial systems and 'mothership' drone control technology. The proposed acquisition from Metal Machinery Components Trading – FZCO involves $7 million in cash consideration payable 90 days after closing. The deal is subject to technical due diligence in Ukraine, including a live flight demonstration of the ICMM system.
Talen Energy Wins $700M Contract from investment grade counterparty in PJM
Talen Energy's subsidiaries Guernsey Power Station and Waterford Power entered into capacity sale transactions with an investment grade counterparty in the PJM market. The primary Guernsey 7-Year Capacity Sale covers 750 MW of capacity from 2029 through 2036 and is expected to generate approximately $100 million in annual revenue.
Incannex Healthcare Inc. reported a net loss from operations of $3.44 million for the quarter ended September 30, 2026, an improvement from a $6.79 million loss in the prior year period, primarily due to reduced general and administrative expenses. The company maintained a strong cash position of $68.27 million and continues to focus on its clinical development pipeline, including drug candidates IHL-42X and IHL-675A.
Vivani Medical announced positive top-line results from its SLIM-1 Phase 1 trial evaluating NPM-139, a miniature semaglutide implant for chronic weight management. The trial demonstrated that NPM-139 was well-tolerated with no treatment-related adverse events and achieved weight loss of 0.79% over four weeks, comparable to the 0.82% observed in the Wegovy control group.
Term
4 weeks
“The third quarter and recent weeks mark a period of strong progress and forward momentum for Vivani. The top-line SLIM-1 results will be announced this week. We look forward to sharing those results with shareholders, industry peers, and the broader community of physicians and patients seeking less frequent dosing and the promise of potential improvements in convenience, medication adherence, and tolerability associated with GLP-1 therapies on the market and in clinical-stage development.”
Adam Mendelsohn, PhD, CEO
“Roughly half of patients don’t take their medications for chronic diseases as prescribed, and GLP-1 therapies are no exception. With NPM-139, we are designing a novel GLP-1 therapy that a patient could receive once or twice a year during a routine primary care visit.”
Perspective Therapeutics CEO Johan M. Spoor Buys $37.9K of Stock
Johan M. Spoor, CEO, bought 47,000 shares of Perspective Therapeutics, Inc. at $0.8073 a share, worth $37.9K in total on Nov 11, 2026. Shares held after the trade: 106,383 (+79.1%).
New Era Energy & Digital (NUAI) is transitioning from a site-only play to an execution-ready data center developer with 757MW capacity and key permits secured.